• Event Times (GMT+1)
  • Local Times (GMT+2)
Posters
Poster Area
Saturday, June 27, 01:20 PM – 01:50 PM
Poster Session 2: Schizophrenia and Bipolar
Possible immunological pathophysiology in bipolar disorder: transcriptome analysis using induced microglia-like (iMG) cells and iPSC derived neurons
The effect of kynurenic acid (KYNA) release on glutamatergic transmission in the hippocampus - a model of schizophrenia
Combining structural neuroimaging and cognitive markers for the identification of clinical high-risk and first-episode schizophrenia
Change-points in patient-reported side effects following initiation of long-acting injectable antipsychotics: a longitudinal LUNSERS analysis
Brain hypometabolism and disorganization domain as putative neuronal correlates in schizophrenia: a comparative head-to-head treatment-resistant vs. treatment-responsive schizophrenia PET study
Music therapy and gardening enhances post-discharge adherence in psychiatric patients
​The influence of psychiatric comorbidity on the level of adherence to psychopharmacotherapy in patients with bipolar disorder
A study on the similarities and differences in brain functional connectivity alterations in schizophrenia and bipolar disorder
Striatal dopamine synthesis trajectory in first-episode psychosis during amisulpride monotherapy and after switch to aripiprazole: a one-year [18F]DOPA PET study
Cortical amyloid-β imaging and psychotic symptoms in treatment-resistant schizophrenia: evidence from a pilot PET study
A high-throughput screening platform for the discovery of selective M1/M4 muscarinic receptor agonists and positive allosteric modulators
Differential longitudinal changes in spontaneous neural activity in treatment-resistant schizophrenia patients undergoing clozapine treatment
Exploring new treatment approach for restoring occupational and social function in schizophrenia: behavioral variation analysis of social/empathic function using lurasidone medication
Phosphoproteomics identifies Rho-Kinase-associated phospho-signaling in the medial prefrontal cortex of a schizophrenia-related mouse model and discloses autophagy dysfunction
Clinical treatment pathways of antipsychotics in patients with schizophrenia spectrum disorder: a retrospective longitudinal observational study
Usefulness of clozapine as maintenance pharmacotherapy after response to acute electroconvulsive therapy in schizophrenia
Cognitive correlates of functional recovery in remitted bipolar disorder
Relationships between clinician adherence to guideline-recommended treatment and memory function in patients with schizophrenia
The U-shaped relationships between prolactin level and insulin resistance in patients with schizophrenia under olanzapine treatment
Disrupted occipital-parietal alpha oscillations in first-episode psychosis
Plasma interleukin-6 levels in antipsychotic-responsive and treatment-resistant schizophrenia in association with clozapine treatment
Co-design and development of iSWITCHED: a theory-informed clinical decision-support tool to enable evidence-based antipsychotic switching in severe mental illness
Immunological characteristics of patients with schizophrenia and various degrees of severity of neurocognitive disorders
Relapse rate, clinical efficacy, and safety of the 3-month paliperidone palmitate in community-dwelling patients with schizophrenia
Maternal immune activation induces neurodevelopmental impairments of adult offspring through alterations in tryptophane-kynurenine pathway in the placenta
Translational relevance of the MAM model in schizophrenia: a systematic review of behavioral and neurobiological findings
Validation study of Korean version of Glasgow antipsychotic side-effect scale for clozapine (GASS-C)
Dual Lipopolysaccharide injection induces prolonged activation of the kynurenine pathway and alters schizophrenia-associated proteins in vivo
Detection of an ultra-rare missense mutation (E263G) in the DRD5 gene segregating with multiple psychiatric diagnoses in a family
Prevalence and incidence of ophthalmologic side effects of antipsychotic medications: a systematic review and meta-analysis
Physical hospitalization burden is lower in severe schizophrenia: evidence of potential barriers to medical care
Personal growth as a result of anti-relapse behavior: 30 years of experience in coping with mental disorder
Effect of cariprazine on psychotic symptoms and impulsivity in first-episode psychosis with comorbid cannabis use: a case series from early intervention services in Greece
Intranasal esketamine in treatment-resistant bipolar depression maintained on long-acting aripiprazole
Neuroscience-guided comprehensive assessment and psychoeducation for bipolar disorder: implications for psychopharmacology practice in an Indonesian academic referral hospital
Rebound mania following abrupt discontinuation of oxcarbazepine in bipolar I disorder: a case report
Targeting kynurenine aminotransferase III: discovery of a selective and brain-penetrant inhibitor for reducing synthesis of immune-induced kynurenic acid
Brain network resilience markers for staging and prognosis
A new nanoformulation of a brain-penetrating VIPR2 antagonist peptide for the treatment of schizophrenia
State-dependent associations between striatal dopamine transporter availability and large-scale brain network in bipolar disorder
Appetite hormone regulation biotypes of major affective disorders in proinflammatory cytokines and executive function
Development of novel add-on treatment of cognitive dysfunction in schizophrenia
Glymphatic system dysfunction, accelerated brain aging, and inflammation in major psychiatric disorders: a transdiagnostic DTI-ALPS study
A brain-enriched Extracellular Vesicles liquid biopsy links bipolar disorder biology to drug candidates through Connectivity Map Analysis